P53 Evaluation of ER, and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer

✍ Scribed by Y. Im; J. Lee; E. Cho; H. Kim; J. Ahn; Y. Park; S. Nam; W. Kang; K. Park; J. Yang

• Book ID: 114315971
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 46 KB
• Volume: 16
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/s0960-9776(07)70118-2